Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Endocrine 1Breast 1

Conditions

Lymphoma 1Leukemia 1Hematologic Diseases 1

Interventions

Cyclophosphamide 296Cytarabine 261fludarabine phosphate 218Rituximab 195fludarabine 182Methotrexate 152Whole-Body Irradiation 140Mycophenolic Acid 124Azacitidine 122Tacrolimus 116Busulfan 110Filgrastim 104Granulocyte Colony-Stimulating Factor 98Etoposide 91Peripheral Blood Stem Cell Transplantation 90Dexamethasone 89Vincristine 88Melphalan 80Cyclosporine 74Lenalidomide 73Daunorubicin 70Decitabine 69Clofarabine 69Antilymphocyte Serum 67Calcium Dobesilate 61venetoclax 60Doxorubicin 58Imatinib Mesylate 57Alemtuzumab 56ibrutinib 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ethanol × Other hematologic neoplasm × Clear all
NCT02095951 2018-12-19

Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection

Children's Hospital of Michigan

Phase 4 Completed
30 enrolled 8 charts
LymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡